Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial. - Wikidata - wikimedia - TriplyDB

Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.

Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.

http://www.wikidata.org/entity/Q36853358

about

Experiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in India The likelihood of participation in clinical trials can be measured: the Clinical Research Involvement Scales.Who participates in internet-based worksite weight loss programs?Enrollment in YFV Vaccine Trial: An Evaluation of Recruitment Outcomes Associated with a Randomized Controlled Double-Blind Trial of a Live Attenuated Yellow Fever Vaccine.Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.Conceptual framework for behavioral and social science in HIV vaccine clinical research.Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda Representation of Latinos and Blacks in screening for and enrollment into preventive HIV vaccine trials in New York City.

P2860

Q30219959-118ACFB7-4F73-4DF3-AD97-38E5BABB2F90 Q33941271-81453BAE-1F47-4C61-B23F-4D069F5C5DB0 Q34024655-94CC7960-9644-4A70-A356-FEE5D4751080 Q34159806-49B426D0-9538-46EA-A410-FF4641486194 Q34376994-21640081-F600-4C76-84A3-998AD871486B Q35187935-88E2EEA6-A70E-4D0E-AC41-14238DB7D172 Q35301155-3DB64E0D-FF76-4F9C-A308-3BD9AA7A5AA9 Q35863340-427853EB-BD7A-4E9C-B1B8-B4A39B052C08 Q37409508-BEFD3A34-1381-460B-8BE4-489E705C307B

P2860

Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.

http://www.wikidata.org/entity/Q36853358

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Understanding differences in e ...... a phase IIb HIV vaccine trial.

@en

type

label

Understanding differences in e ...... a phase IIb HIV vaccine trial.

@en

prefLabel

Understanding differences in e ...... a phase IIb HIV vaccine trial.

@en

P1433

Q36853358-EA7BF285-10C0-4ED6-9D97-9BA9FA399BB9

P1476

Q36853358-97E1A245-99D3-4C1A-BC84-D7A0F2C41836

P2093

Q36853358-2D7365FD-4157-42B2-B8C4-2398BD94BDDD

Q36853358-4AF85663-5F20-4641-A742-6D0F4BC63C57

Q36853358-A8D8168C-53B4-4930-83E8-2228C872C3D0

Q36853358-BF732F74-9838-42A0-A0B9-A6B5246EB4AE

P2860

Q36853358-00A69F92-1CBF-44E8-8AFB-403236C5B8F7

Q36853358-1126444F-8569-4F8F-9FEA-8B44E22479A8

Q36853358-19AD0C52-BC26-4EDD-9A2D-3B9ED9F1AD93

Q36853358-1F61EEF8-F5B1-4B7F-8EAE-3982B0253339

Q36853358-46C05731-7866-42FD-BB5A-89ECF665BF79

Q36853358-49EF87C0-1D7A-4EBA-A82F-6B7B03835779

Q36853358-5875AFD7-7C7C-4BDD-B15A-B899ABBFBE3B

Q36853358-68181C7C-3B07-4EF2-A2CC-2F80D07C4926

Q36853358-6D176A3F-1741-4A55-8F33-F70C5702B13F

Q36853358-7ED292F9-25C0-48FD-9980-D67BBF9F6DE7

P304

Q36853358-D37E8F18-9E8C-4B40-92CE-D47FA2A27F88

P31

Q36853358-76D63D66-42F1-49E1-AF9D-3422C5AF63EA

P356

Q36853358-ABC81982-724E-4F05-A4A6-6484E71E03CE

P407

Q36853358-A896DAA2-B514-4702-B386-8DE5CCC2D70D

P433

Q36853358-BAD18FA5-A599-4BBE-A32E-022937FA27C9

P478

Q36853358-519E7BD8-9090-44C3-A5BE-9F7847D47C10

P50

Q36853358-130DEB01-994D-41B7-A3CC-2039F2B798E5

P577

Q36853358-AACC026F-E16C-49A1-A10D-BEF8BBDF7452

P698

Q36853358-8D618CFC-795F-4717-AB5C-F183B472CF43

P932

Q36853358-D120CE88-A77B-42EC-878C-EC978D4C369F

P356

QAI.0B013E3181945EEC

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Understanding differences in e ...... a phase IIb HIV vaccine trial.

@en

P2093

Carlos del Rio

http://www.w3.org/2001/XMLSchema#string

Lu Lu

http://www.w3.org/2001/XMLSchema#string

Mark J Mulligan

http://www.w3.org/2001/XMLSchema#string

Sarah Clifton

http://www.w3.org/2001/XMLSchema#string

P2860

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.

Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.

In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study

Willingness to participate in HIV vaccine trials: the impact of trial attributes.

Estimation of HIV incidence in the United States.

Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.

Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?

Evaluating minority recruitment into clinical studies: how good are the data?

P304

314-319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181945EEC

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19194310

http://www.w3.org/2001/XMLSchema#string

P932

3657343

http://www.w3.org/2001/XMLSchema#string